Urinalysis Market Size, Share & Industry Analysis, By Product Type (Instruments, Consumables), By Application (Pregnancy and Fertility, Disease Screening), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgery Centres, Diagnostic Centers, Others)Others and Regional Forecast, 2024-2032

Urinalysis is a convenient and effective method of analysing the urine samples to detect various infections and chronic diseases such as diabetes, urinary tract infection, kidney disease, etc. The test consists of several visual, microscopic, and chemical examinations that identify cells, protein, levels of creatinine, and substances such as crystals in the urine which help in the detection of various diseases. It also helps to identify the cause of symptoms such as back pain, abdominal pain, and painful urination. The rising prevalence of chronic diseases such as diabetes, urinary tract infection, kidney disease is expected to drive the growth of the market. Furthermore, rising geriatric population, increasing initiatives undertaken by the government for growing awareness among the population, and advancements in technology innovations of urinalysis are anticipated to boost the urinalysis market growth during the forecast period. For instance, in July 2018, Beckman Coulter, Inc. and ARKRAY, Inc. merged and launched iQ Urinalysis Workcell and integrated automated urine analyzer.     

An increase in the prevalence of chronic diseases such as diabetes, urinary tract infections, kidney disease; advancements in technology innovations of urinalysis; and rising geriatric population are some of the factors that are expected to drive the growth of the market. According to The National Center for Biotechnology Information, globally, about 6 million people are diagnosed with urinary tract infections every year.

Key Market Driver -

Increasing prevalence of chronic diseases, advancements in technology innovations of urinalysis

Key Market Restraint -

Inadequate healthcare access in developing countries, high costs associated with urinalysis

Also, initiatives taken by the government and private organizations for increasing awareness about the urinalysis is expected to further drive the growth in the global urinalysis market.

However, the high cost of the urinalysis tests and inadequate healthcare access in developing countries are the major factors that can inhibit the growth in the global urinalysis market.

Key Players Covered:

Some of the major companies that are present in the urinalysis market are F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc., Sysmex Corporation, ARKRAY, Inc., ACON Laboratories, Inc., Bio-Rad Laboratories, Inc., Urit Medical Electronics Co., Ltd., and other prominent players.

Market Segmentation:

In terms of product type, the urinalysis market can be segmented into instruments and consumables. The instruments segment can be further categorized into chemistry analyser, microscopy/sediment analyser, integrated chemistry and sediment analyser, and others. The consumables segment can be further sub-segmented into plastic consumables, reagent and strip, and chemical agents. By application, the market can be segmented into pregnancy and fertility; and disease screening. By end users, the market can be divided into hospital, specialty clinics, ambulatory surgery centres, diagnostic centers, and others.

Geographically, the urinalysis market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Key Insights

• Prevalence of Chronic Diseases by Key Countries, Key Regions


• Technological Advancements in Urinalysis Methods


• New Product Launches


• Recent Industry Developments Such as Partnerships, Mergers, And Acquisitions

Regional Analysis:

The global urinalysis market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold the largest market share of urinalysis market during the forecast period due to the factors such as the increasing prevalence of chronic diseases, increased research activities in the field of urinalysis, and growing awareness among the population about urinalysis. According to the National Diabetes Statics Report 2017, about 30.3 million Americans (nearly 1 in 10) suffer from diabetes. Europe, on the other hand, is projected to have the second-largest share in the urinalysis market due to the rising prevalence of urinary tract infections and increasing government initiatives for raising awareness about the urinalysis among the population.

To gain extensive insights into the market, Request for Customization

The Asia Pacific and Latin America are anticipated to have a comparatively fast market growth in the upcoming years. Increasing adoption of advanced urine analyzers and a rising geriatric population which is more prone to chronic diseases are some of the factors that are expected to drive the market growth. The market in the Middle East and Africa is projected to have substantial growth by the end of the forecast period.    

Segmentation

Global Urinalysis Industry Developments    

• In January 2019, Bio-Rad Laboratories, Inc. launched qUAntify Advance Control, an independent quality control used to monitor the precision of laboratory urinalysis test procedures.


• In July 2018, Beckman Coulter, Inc. and ARKRAY, Inc. merged and launched iQ Urinalysis Workcell, and integrated automated urine analyzer.


• In January 2016, Sysmex Corporation launched UD-10 fully-automated imaging unit, product in the sediment urinalysis testing field for testing the formed elements in the urine